ImageneBio, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $193.0M | $46.9M |
| Jun 2022 | — | $174.4M | $48.5M |
| Sep 2022 | — | $158.8M | $67.1M |
| Dec 2022 | — | $147.0M | $59.9M |
| Mar 2023 | — | $135.0M | $29.3M |
| Jun 2023 | — | $156.7M | $70.9M |
| Sep 2023 | — | $155.3M | $121.3M |
| Dec 2023 | — | $-126.1M | $119.9M |
| Mar 2024 | — | $-137.3M | $52.9M |
| Jun 2024 | — | $-146.6M | $44.3M |
| Sep 2024 | — | $-152.8M | $45.2M |
| Dec 2024 | — | $-160.6M | $12.1M |
| Mar 2025 | — | $-169.6M | $36.8M |
| Jun 2025 | — | $-180.4M | $58.3M |
| Sep 2025 | — | $139.8M | $103.2M |
| Dec 2025 | — | $133.1M | $94.5M |
| Mar 2026 | — | $123.3M | $76.0M |
| Jun 2026 | — | $142.1M | $94.7M |